Carnot Labs, Inc. — SEC Form D Filing
Carnot Labs, Inc. filed an SEC Form D on July 23, 2026, reporting $4.95M raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 23, 2026
- Amount reported
- $4.95M
- Industry
- Pharmaceuticals
- Website
- https://www.carnot.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
People suffer from various health conditions such as vaginal infections, allergic rhinitis, and other ailments, and couples need solutions for family planning.
Solution
Carnot Labs develops new pharmaceutical products to address these health issues and provides information and methods related to family planning and contraception.
Verdict
Investors backed this endeavor due to the perceived market size for common ailments and family planning, implying a bet on broad, undifferentiated demand rather than novel scientific breakthroughs. This cleared because of the established need for basic pharmaceutical products, not because of a compelling innovation or proprietary technology described. The lack of specificity regarding intellectual property or unique formulations inherently limited the upside to incremental market capture rather than disruptive gains.
Source: SEC EDGAR Form D filing